Cardiomyopathy is a disease that affects the heart muscle (known as the myocardium). There are different types of cardiomyopathy. Each of these cause damage to the heart muscle, such as enlarging ...

Rates of arrhythmic events and death remained common in patients indicated for implantable cardioverter defibrillator or ...

[Yancy 2013;15a] Of the cardiomyopathy-causing amyloidoses listed above, the most common are AL amyloidosis and hereditary and wild-type TTR amyloidosis. [Muchtar 2017;3g] It is these three ...

Though women have a lower risk of ventricular arrhythmias than do men, it still exceeds the threshold to justify a device.

on 31 March 2025 for the treatment of the cardiomyopathy of wild-type or hereditary ATTR-CM. It is currently under review by the Japanese Pharmaceuticals and Medical Devices Agency (PMDA).

Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNA interference (RNAi) therapeutics company, today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European ...

A CNIC team has designed a gene-therapy strategy that could transform the treatment of arrhythmogenic right ventricular cardiomyopathy type 5 (ARVC5), a rare and deadly heritable disease that ...

UK MHRA grants marketing authorization to Bayer’s acoramidis to treat wild-type or variant transthyretin amyloidosis in adults with cardiomyopathy: United Kingdom Monday, April ...